Showing 1 - 11 results of 11 for search 'Alexei A. Grom', query time: 0.04s Refine Results
  1. 1
    SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: MECHANISMS OF DEVELOPMENT AND TARGETS FOR GENETIC ENGINEERING BIOLOGICAL THERAPY

    SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: MECHANISMS OF DEVELOPMENT AND TARGETS FOR GENETIC ENGINEERING BIOLOGICAL THERAPY by Alexei A. Grom

    Published 2012-05-01
    Get full text
    Article
  2. 2
    The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study

    The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study by Fabrizio de Benedetti, Alexei A. Grom, Hermine Brunner

    Published 2024-01-01
    Get full text
    Article
  3. 3
    The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA

    The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA by Grant Schulert, Sebastiaan J. Vastert, Alexei A. Grom

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022

    Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022 by Rashmi Sinha, Fabrizio De Benedetti, Alexei A. Grom, on behalf of the participants listed below

    Published 2024-01-01
    Get full text
    Article
  5. 5
    Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease

    Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease by Rachel A. Brown, Maggie Henderlight, Thuy Do, Shima Yasin, Shima Yasin, Alexei A. Grom, Alexei A. Grom, Monica DeLay, Sherry Thornton, Sherry Thornton, Grant S. Schulert, Grant S. Schulert

    Published 2018-12-01
    Get full text
    Article
  6. 6
    The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis

    The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis by Najla Aljaberi, Elena Tronconi, Grant Schulert, Alexei A. Grom, Daniel J. Lovell, Jennifer L. Huggins, Michael Henrickson, Hermine I. Brunner

    Published 2020-01-01
    Get full text
    Article
  7. 7
    Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis

    Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis by Emely L. Verweyen, Kairavee Thakkar, Sanjeev Dhakal, Elizabeth Baker, Kashish Chetal, Daniel Schnell, Scott Canna, Alexei A. Grom, Nathan Salomonis, Grant S. Schulert

    Published 2023-11-01
    Get full text
    Article
  8. 8
    Urine S100 proteins as potential biomarkers of lupus nephritis activity

    Urine S100 proteins as potential biomarkers of lupus nephritis activity by Jessica L. Turnier, Ndate Fall, Sherry Thornton, David Witte, Michael R. Bennett, Simone Appenzeller, Marisa S. Klein-Gitelman, Alexei A. Grom, Hermine I. Brunner

    Published 2017-10-01
    Get full text
    Article
  9. 9
    Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States

    Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States by Peter Hur, Kathleen G. Lomax, Raluca Ionescu-Ittu, Ameur M. Manceur, Jipan Xie, Jordan Cammarota, Raju Gautam, Navneet Sanghera, Nina Kim, Alexei A. Grom

    Published 2021-09-01
    Get full text
    Article
  10. 10
    IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome

    IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome by Denny K. Gao, Nathan Salomonis, Maggie Henderlight, Christopher Woods, Kairavee Thakkar, Alexei A. Grom, Sherry Thornton, Michael B. Jordan, Kathryn A. Wikenheiser-Brokamp, Grant S. Schulert

    Published 2021-09-01
    Get full text
    Article
  11. 11
    Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe

    Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe by Alexei A. Grom, Scott W. Canna, Rolla F. Abu-Arja, Rashmi Sinha, Luciana Peixoto, Elvira Cannizzaro, Shanmuganathan Chandrakasan, Kyla Driest, Rebecca Marsh, Bénédicte Neven, Karen Onel, Sampath Prahalad, Susan Prockop, Pierre Quartier, Johannes Roth, Grant Schulert, Juliana M.F. Silva, Donna Wall, Ulrike Zeilhofer

    Published 2024-01-01
    Get full text
    Article

Search Tools: